Natera’s Strong Financial Performance and Growth Potential Reinforce Buy Rating
PremiumRatingsNatera’s Strong Financial Performance and Growth Potential Reinforce Buy Rating
29d ago
USPTO issues Natera new patent related to testing of ctDNA
Premium
The Fly
USPTO issues Natera new patent related to testing of ctDNA
1M ago
Natera price target raised to $205 from $200 at Piper Sandler
Premium
The Fly
Natera price target raised to $205 from $200 at Piper Sandler
1M ago
Natera price target raised to $195 from $180 at Canaccord
PremiumThe FlyNatera price target raised to $195 from $180 at Canaccord
1M ago
Natera’s Strong Growth Potential: Buy Rating Affirmed Amidst Robust Sales Guidance and Product Performance
Premium
Ratings
Natera’s Strong Growth Potential: Buy Rating Affirmed Amidst Robust Sales Guidance and Product Performance
1M ago
Natera Inc. Reports Strong Revenue Growth in 2024
Premium
Company Announcements
Natera Inc. Reports Strong Revenue Growth in 2024
1M ago
Is NTRA a Buy, Before Earnings?
PremiumPre-EarningsIs NTRA a Buy, Before Earnings?
1M ago
Natera comments on updated NCCN guidance for circulating tumor DNA
Premium
The Fly
Natera comments on updated NCCN guidance for circulating tumor DNA
2M ago
Natera’s Promising RhD Test Developments and Revenue Growth Potential: A Buy Recommendation
Premium
Ratings
Natera’s Promising RhD Test Developments and Revenue Growth Potential: A Buy Recommendation
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100